{"gao_id": "GAO-22-105248", "published": "2022-06-16T12:00:00Z", "released": "2022-06-16T08:00:00Z", "summary": "Past bioterrorist attacks, such as the anthrax attacks of 2001, highlight the threats posed by chemical, biological, radiological, and nuclear agents\u2014and the importance of medical countermeasures to treat people in the aftermath. FDA established the Animal Rule in 2002 to allow for the approval of medical countermeasures based on animal studies when human clinical trials are not ethical or feasible. We found that FDA has...", "title": "Public Health Preparedness: Medical Countermeasure Development for Certain Serious or Life-Threatening Conditions", "topics": ["Biologics", "Health care", "Product development", "Drugs", "Anthrax", "Animals", "Medical countermeasures", "Clinical trials", "Research organizations", "Health Care", "Information sharing"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-22-105248", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-22-105248-highlights.pdf"}, {"title": "Full Report (30 pages)", "url": "https://www.gao.gov/assets/gao-22-105248.pdf"}]}